Please use this identifier to cite or link to this item: https://dspace.uzhnu.edu.ua/jspui/handle/lib/10571
Full metadata record
DC FieldValueLanguage
dc.contributor.authorM. Ducreux-
dc.contributor.authorG. Wilson-
dc.contributor.authorA. Cervantès-
dc.contributor.authorT. André-
dc.contributor.authorY. Hotko-
dc.contributor.authorF. Lordick-
dc.contributor.authorS. Collins-
dc.contributor.authorM. Shing-
dc.contributor.authorT. Price-
dc.contributor.authorM. Peeters-
dc.date.accessioned2016-11-09T09:17:26Z-
dc.date.available2016-11-09T09:17:26Z-
dc.date.issued2009-03-
dc.identifier.urihttps://dspace.uzhnu.edu.ua/jspui/handle/lib/10571-
dc.language.isofruk
dc.publisherGastroentérologie Clinique et Biologique Vol 33, N° HS1 - mars 2009 p. 139uk
dc.subjectFOLFIRI, cancers colorectaux métastasés,uk
dc.titleEtude de phase III (20050181) de l’association panitumumab + 5-fluorouracile, acide folinique, irinotecan (Folfiri) versus Folfiri seul en seconde ligne de traitement des cancers colorectaux métastasés. Analyse poolée de toxicitéuk
dc.typeTextuk
dc.pubTypeСтаттяuk
Appears in Collections:Наукові публікації кафедри радіології та онкології



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.